Bone marrow absorbed doses and correlations with hematologic response during 177Lu-DOTATATE treatments are influenced by image-based dosimetry method …

L Hagmarker, J Svensson, T Rydén… - Journal of Nuclear …, 2019 - Soc Nuclear Med
This study aimed to compare different image-based methods for bone marrow dosimetry and
study the dose–response relationship during treatment with 177 Lu-DOTATATE in patients …

[HTML][HTML] A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity

J Svensson, T Rydén, L Hagmarker, J Hemmingsson… - EJNMMI physics, 2016 - Springer
Background 177 Lu-DOTATATE is a valuable treatment option for patients with advanced
neuroendocrine tumours overexpressing somatostatin receptors. Though well tolerated in …

[HTML][HTML] Radiation exposure of the spleen during 177Lu-DOTATATE treatment and its correlation with haematological toxicity and spleen volume

J Svensson, L Hagmarker, T Magnander, B Wängberg… - EJNMMI physics, 2016 - Springer
Background Somatostatin analogue-based radionuclide therapy with 177 Lu-DOTATATE is
an important treatment option for patients with advanced neuroendocrine tumours …

[HTML][HTML] Optimizing the Schedule of PARP Inhibitors in Combination with 177Lu-DOTATATE: A Dosimetry Rationale

A Hallqvist, J Svensson, L Hagmarker, I Marin, T Rydén… - Biomedicines, 2021 - mdpi.com
177 Lu-DOTATATE for neuroendocrine tumours is considered a low-toxicity treatment and
may therefore be combined with other pharmaceuticals to potentiate its efficacy. One …

Segmentation of Whole-Body Images into Two Compartments in Model for Bone Marrow Dosimetry Increases the Correlation with Hematological Response in 177Lu …

L Hagmarker, J Svensson, T Rydén… - Cancer Biotherapy …, 2017 - liebertpub.com
Background: In 177 Lu-DOTATATE treatments, bone marrow (BM) is one of the most
important organs at risk. The authors previously developed an image-based two-compartment …

A new quantitative image-based method for evaluation of bony temporal hollowing in metopic synostosis

L Hagmarker, MB Söfteland, G Maltese… - Journal of Plastic …, 2016 - Taylor & Francis
Objective: Premature craniosynostosis is a congenital disorder causing a skull deformity. For
both functional and cosmetic reasons, the deformity is surgically treated with a cranioplasty …

Temporal deformity objectively measured before and after surgery for metopic synostosis: retrusion rather than hollowing

…, G Maltese, P Tarnow, L Hagmarker… - Journal of …, 2017 - journals.lww.com
The temporal contour deformity typical of metopic synostosis is often referred to as temporal
hollowing, but has not been quantitatively defined. This deformity is present before surgery …

Patient-Specific Dosimetry May Improve Neuroendocrine Tumor Therapy

K Stephens - AXIS Imaging News, 2019 - search.proquest.com
… marrow, enabling a more personalized dosimetry,” explains Linn Hagmarker, PhD, a student
at the … Looking at further implications of this research, Hagmarker notes, “Current evidence …

[PDF][PDF] Restaurering av hagmarker–hur man kan få bukt med örnbräken

Ö Pteridium - Svensk Botanisk Tidskrift, 2005 - researchgate.net
… Våra egna observationer i en eftersatt men nyligen restaurerad hagmark där örnbräken
brett ut sig, är att får trots allt äter av äldre bladskivor. Fåren lämnar av okänd anledning hela …

[CITATION][C] Bone metastases affect bone marrow response during 177-Lu-DOTATATE treatments

J Svensson, L Hagmarker, T Rydén, R Hermann… - 2017 - EANM'17